These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18094432)

  • 1. Evidence for microtubule target engagement in tumors of patients receiving ixabepilone.
    Zhuang SH; Hung YE; Hung L; Robey RW; Sackett DL; Linehan WM; Bates SE; Fojo T; Poruchynsky MS
    Clin Cancer Res; 2007 Dec; 13(24):7480-6. PubMed ID: 18094432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.
    Huang H; Menefee M; Edgerly M; Zhuang S; Kotz H; Poruchynsky M; Huff LM; Bates S; Fojo T
    Clin Cancer Res; 2010 Mar; 16(5):1634-41. PubMed ID: 20179242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.
    Burotto M; Edgerly M; Poruchynsky M; Velarde M; Wilkerson J; Kotz H; Bates S; Balasubramaniam S; Fojo T
    Oncologist; 2015 Jul; 20(7):725-6. PubMed ID: 26040622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.
    Low JA; Wedam SB; Lee JJ; Berman AW; Brufsky A; Yang SX; Poruchynsky MS; Steinberg SM; Mannan N; Fojo T; Swain SM
    J Clin Oncol; 2005 Apr; 23(12):2726-34. PubMed ID: 15837987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of ixabepilone and its interactions with the βIII-tubulin isotype.
    Lopus M; Smiyun G; Miller H; Oroudjev E; Wilson L; Jordan MA
    Cancer Chemother Pharmacol; 2015 Nov; 76(5):1013-24. PubMed ID: 26416565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubulin posttranslational modifications induced by cadmium in the sponge Clathrina clathrus.
    Ledda FD; Ramoino P; Ravera S; Perino E; Bianchini P; Diaspro A; Gallus L; Pronzato R; Manconi R
    Aquat Toxicol; 2013 Sep; 140-141():98-105. PubMed ID: 23765032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes.
    Denduluri N; Low JA; Lee JJ; Berman AW; Walshe JM; Vatas U; Chow CK; Steinberg SM; Yang SX; Swain SM
    J Clin Oncol; 2007 Aug; 25(23):3421-7. PubMed ID: 17606971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
    Trivedi M; Budihardjo I; Loureiro K; Reid TR; Ma JD
    Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranslational modifications of alpha tubulin: detyrosination and acetylation differentiate populations of interphase microtubules in cultured cells.
    Bulinski JC; Richards JE; Piperno G
    J Cell Biol; 1988 Apr; 106(4):1213-20. PubMed ID: 3283150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
    Cortes J; Baselga J
    Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
    Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
    Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
    Posadas EM; Undevia S; Manchen E; Wade JL; Colevas AD; Karrison T; Vokes EE; Stadler WM
    Cancer Biol Ther; 2007 Apr; 6(4):490-3. PubMed ID: 17457044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
    Yardley DA
    Clin Breast Cancer; 2008 Dec; 8(6):487-92. PubMed ID: 19073502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of other microtubule-stabilizer families: the epothilones and their derivatives.
    Brogdon CF; Lee FY; Canetta RM
    Anticancer Drugs; 2014 May; 25(5):599-609. PubMed ID: 24398663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and prostate cancer cells display distinct molecular profiles of alpha-tubulin posttranslational modifications.
    Soucek K; Kamaid A; Phung AD; Kubala L; Bulinski JC; Harper RW; Eiserich JP
    Prostate; 2006 Jun; 66(9):954-65. PubMed ID: 16541425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
    Rivera E; Lee J; Davies A
    Oncologist; 2008 Dec; 13(12):1207-23. PubMed ID: 19088324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer.
    Morris PG; Fornier MN
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):115-22. PubMed ID: 19367253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylated and detyrosinated alpha-tubulins are co-localized in stable microtubules in rat meningeal fibroblasts.
    Cambray-Deakin MA; Burgoyne RD
    Cell Motil Cytoskeleton; 1987; 8(3):284-91. PubMed ID: 3319198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.